Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studies
about
Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studiesHIV infection and older Americans: the public health perspectivePopulation health impact and cost-effectiveness of tuberculosis diagnosis with Xpert MTB/RIF: a dynamic simulation and economic evaluationSurvival in HIV-infected patients after a cancer diagnosis in the cART Era: results of an italian multicenter studyCause-Specific Mortality in HIV-Positive Patients Who Survived Ten Years after Starting Antiretroviral TherapyInitiation of antiretroviral therapy.Pretreatment CD4 cell slope and progression to AIDS or death in HIV-infected patients initiating antiretroviral therapy--the CASCADE collaboration: a collaboration of 23 cohort studies.Sex differences in HIV outcomes in the highly active antiretroviral therapy era: a systematic reviewLate-disease stage at presentation to an HIV clinic in the era of free antiretroviral therapy in Sub-Saharan AfricaCohort profile: Antiretroviral Therapy Cohort Collaboration (ART-CC).French 2013 guidelines for antiretroviral therapy of HIV-1 infection in adults.Effect of early versus deferred antiretroviral therapy for HIV on survival.Impact of earlier HAART initiation on the immune status and clinical course of treated patients on the basis of cohort data of the German Competence Network for HIV/AIDS.Spiritual and mind-body beliefs as barriers and motivators to HIV-treatment decision-making and medication adherence? A qualitative studyWhen to initiate combined antiretroviral therapy to reduce mortality and AIDS-defining illness in HIV-infected persons in developed countries: an observational study.Cost-effectiveness of HIV screening in STD clinics, emergency departments, and inpatient units: a model-based analysisReclassification of risk of death with the knowledge of D-dimer in a cohort of treated HIV-infected individuals.Hospitalizations in a cohort of HIV patients in Australia, 1999-2007Cost-effectiveness of early versus standard antiretroviral therapy in HIV-infected adults in HaitiInitiating patients on antiretroviral therapy at CD4 cell counts above 200 cells/microl is associated with improved treatment outcomes in South Africa.Factors associated with paradoxical immune response to antiretroviral therapy in HIV infected patients: a case control study.Retention of HIV-infected and HIV-exposed children in a comprehensive HIV clinical care programme in Western Kenya.How HIV treatment could result in effective preventionInfluence of gender on loss to follow-up in a large HIV treatment programme in western Kenya.The cost-effectiveness and value of information of three influenza vaccination dosing strategies for individuals with human immunodeficiency virus.Treatment to prevent transmission of HIV-1Immunologic and virologic events in early HIV infection predict subsequent rate of progression.Actual and undiagnosed HIV prevalence in a community sample of men who have sex with men in Auckland, New ZealandEffectiveness of first-line antiretroviral therapy in the IPEC cohort, Rio de Janeiro, Brazil.Mortality in patients with HIV-1 infection starting antiretroviral therapy in South Africa, Europe, or North America: a collaborative analysis of prospective studiesA mathematical model of comprehensive test-and-treat services and HIV incidence among men who have sex with men in the United States.Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy.Infrequent HIV testing and late HIV diagnosis are common among a cohort of black men who have sex with men in 6 US cities.Treatment initiation, program attrition and patient treatment outcomes associated with scale-up and decentralization of HIV care in rural Malawi.Estimation of HIV-testing rates to maximize early diagnosis-derived benefits at the individual and population levelVariable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy: not all AIDS-defining conditions are created equalLate HIV diagnosis is a major risk factor for intensive care unit admission in HIV-positive patients: a single centre observational cohort studyWomen experience a better long-term immune recovery and a better survival on HAART in Lao People's Democratic Republic.Older HIV-infected individuals present late and have a higher mortality: Brighton, UK cohort study.Antiretroviral treatment 2010: progress and controversies.
P2860
Q24656950-9DFC40C1-E453-4B11-ACE1-C3FBD30A49FAQ26858824-54B5A548-1A6D-40A2-9D9C-331F04906E6EQ28485280-3B57D7DD-D396-40B9-B538-A4AA0722DB7EQ28538165-CB06B78B-ADDC-43DE-A466-973FB6FE3901Q28553516-5A8FF17F-EB5B-4DF9-AB4C-C0EF0E670C99Q30209635-489E0B01-75EE-42DF-984B-2187494BFFB1Q33534635-F3D52C2D-8D9F-4F96-B016-221116787AFFQ33566578-7CA2F874-A4B5-40EB-AA34-E7539F238DB0Q33625803-C2E00631-0FBA-4F68-91B1-DF7BFA517214Q33736040-413B6FEE-906F-448F-8CB0-6759C641CD92Q33775397-42EC20EE-D665-4D21-B967-82707FF5861FQ33789114-FF32D907-2079-4B0F-974C-3E7261ABE749Q33790033-AD0482E7-6EED-4121-9F04-579733530281Q33797894-2EB7917A-0C78-49A9-9DBF-03FA15F7C7F2Q33876261-DFA53FE6-B285-4ABE-AB79-E013173CD03BQ33916355-E7347F52-0822-47E2-B9F0-EA48839E1F94Q33917180-71E9A783-A00E-43FB-A453-E8ADC82050EFQ33924662-0BCDD813-250D-42C8-9537-3054B26F5A90Q34031173-01ACE192-E007-4C31-A48C-55F10FEC2FAEQ34040005-0EC911C1-3417-4332-9B9B-1B193583E017Q34065045-EE39DF4E-8B79-4FA3-B887-DED0A7E245A7Q34088780-A34970CA-76A0-43DB-AEC3-B6131260E4A3Q34090397-15AA8920-9228-49B5-AE11-A9C49B67B775Q34092713-5200F9D6-0D5F-48FE-90C6-AA92179CEE5FQ34097791-9B8B7933-9162-4E8F-A9BA-0BACA69770C4Q34102424-E52361A1-0EBF-4A88-A1A6-B150AFE417C8Q34127870-033D80DA-DC2D-4316-A227-53135B8D9C5BQ34148147-AA47BAB9-1754-4529-B8DD-2BA7FB68925CQ34153838-201C6E9B-ED6E-42DA-BBDD-570E026891A9Q34155253-5CDF103D-DBE2-4277-81BB-F620701EE886Q34163174-49B74E96-BE49-4903-B3C1-EEE48EFD8863Q34405742-AE72B483-FC76-4CB3-A163-A4547112E891Q34422229-1D603F45-1443-4E3E-9653-87469C46F4D5Q34450196-741E04D2-8027-4B5E-9C5C-37FB2B8F1A25Q34544751-9AC5C0BC-7DC4-4F20-BFFA-EB2DA3F6F169Q34546056-B5555AD8-D441-4BF0-9A79-616442675A16Q34554118-584ECEE0-4EC1-43A3-BB12-2775DC839C9AQ34556999-CF4200B8-E21F-4D8C-8738-2A4612773F74Q34691316-FF9DB9EA-03E2-4DE5-91EC-F84A6F778157Q34701261-2CBE30AB-E6B3-4792-A56E-C845CBD28E0C
P2860
Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studies
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Prognosis of HIV-1-infected pa ...... nalysis of prospective studies
@ast
Prognosis of HIV-1-infected pa ...... nalysis of prospective studies
@en
type
label
Prognosis of HIV-1-infected pa ...... nalysis of prospective studies
@ast
Prognosis of HIV-1-infected pa ...... nalysis of prospective studies
@en
prefLabel
Prognosis of HIV-1-infected pa ...... nalysis of prospective studies
@ast
Prognosis of HIV-1-infected pa ...... nalysis of prospective studies
@en
P2093
P2860
P50
P1433
P1476
Prognosis of HIV-1-infected pa ...... nalysis of prospective studies
@en
P2093
Amy C Justice
Andrew Phillips
Antiretroviral Therapy (ART) Cohort Collaboration
Antonella D'Arminio Monforte
Bruno Ledergerber
Jonathan A C Sterne
Norbert Schmeisser
Peter Reiss
Shlomo Staszewski
P2860
P304
P356
10.1097/QAD.0B013E328133F285
P407
P50
P577
2007-05-01T00:00:00Z